LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
MCF 10A-H2B-mCherry Dasatinib
0.31623
 95.70 27.76 3678 6712 0.5480 0.6862
MCF 10A-H2B-mCherry Palbociclib
0.0033333
 95.70 27.76 8602 6712 1.2815 0.9824
MCF 10A-H2B-mCherry Etoposide
0.056667
 95.70 27.76 6706 6712 0.9991 0.8506
MCF 10A-H2B-mCherry Palbociclib
0.0010833
 95.70 27.76 5847 6712 0.8712 0.7696
MCF 10A-H2B-mCherry Alpelisib
0.31623
 95.70 27.76 7093 6712 1.0567 0.9927
MCF 10A-H2B-mCherry Palbociclib
1.7783
 95.70 27.76 1480 6712 0.2206 0.6080
MCF 10A-H2B-mCherry Trametinib
0.001
 95.70 27.76 8102 6712 1.2070 1.0347
MCF 10A-H2B-mCherry Dasatinib
0.0033333
 95.70 27.76 7130 6712 1.0623 0.8980
MCF 10A-H2B-mCherry Dasatinib
0.17783
 95.70 27.76 2855 6712 0.4253 0.5826
MCF 10A-H2B-mCherry Trametinib
0.017783
 95.70 27.76 1506 6712 0.2245 0.6016
MCF 10A-H2B-mCherry Neratinib
3.1623
 95.70 27.76 2 6712 0.0004 -0.2970
MCF 10A-H2B-mCherry Trametinib
1
 95.70 27.76 397 6712 0.0592 0.1920
MCF 10A-H2B-mCherry Etoposide
1.7783
 95.70 27.76 539 6712 0.0803 0.2101
MCF 10A-H2B-mCherry Neratinib
0.0053333
 95.70 27.76 6537 6712 0.9738 0.8196
MCF 10A-H2B-mCherry Trametinib
0.00033333
 95.70 27.76 6854 6712 1.0211 0.7129
MCF 10A-H2B-mCherry Dasatinib
0.1
 95.70 27.76 2000 6712 0.2980 0.5394
MCF 10A-H2B-mCherry Neratinib
0.17783
 95.70 27.76 2657 6712 0.3959 0.7259